Clinical Trial Update: A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections [Phase 4]

View source ↗

Summary

Pfizer-sponsored Phase 4 study evaluating the efficacy and safety of voriconazole in Chinese patients with serious deep tissue fungal infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Invasive Fungal Infections | Phase 4 | Status: COMPLETED